Herpes Zoster Vaccine, Live

Developed for: herpes zoster
Investigated by: Center for Disease Control and Prevention, Fujian · Changchun BCHT Biotechnology Co. · Inner Mongolia Center for Disease Control and Prevention

today NCT06961721 · Ph 4

2026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT06961721	May → Jul 2025 overdue	herpes zoster	Changchun BCHT Biotechnology Co.	Not yet recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Herpes Zoster Vaccine, Live	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06961721 ↗
Modality	Vaccine	“live attenuated herpes zoster vaccine” NCT06961721 ↗